Logo image
Genetic Modifiers of Patent Ductus Arteriosus in Term Infants
Journal article   Open access   Peer reviewed

Genetic Modifiers of Patent Ductus Arteriosus in Term Infants

Priti M Patel, Allison M Momany, Kendra L Schaa, Paul A Romitti, Charlotte Druschel, Margaret E Cooper, Mary L Marazita, Jeffrey C Murray and John M Dagle
The Journal of pediatrics, Vol.176, pp.57-61.e1
09/2016
DOI: 10.1016/j.jpeds.2016.05.066
PMCID: PMC5003735
PMID: 27344223
url
http://doi.org/10.1016/j.jpeds.2016.05.066View
Open Access

Abstract

To identify single-nucleotide polymorphisms (SNPs) in specific candidate genes associated with patent ductus arteriosus in term infants. We conducted an initial family-based, candidate gene study to analyze genotype data from DNA samples obtained from 171 term infants and their parents enrolled in the National Birth Defects Prevention Study (NBDPS). We performed transmission disequilibrium testing (TDT) using a panel of 55 SNPs in 17 genes. Replication of SNPs with P < .1 in the NBDPS trios was performed with a case-control strategy in an independent population. TDT analysis of the NBDPS trios resulted in 6 SNPs reaching the predetermined cutoff (P < .1) to be included in the replication study. These 6 SNPs were genotyped in the independent case-control population. A SNP in TGFBR2 was found to be associated with term patent ductus arteriosus in both populations after we corrected for multiple comparisons. (rs934328, TDT P = 2 × 10−4, case-control P = 6.6 × 10−5). These findings confirm the importance of the transforming growth factor-beta pathway in the closure of the term ductus arteriosus and may suggest new therapeutic targets.
CREBB candidate gene TRAF1 TGFBR2

Details

Metrics

Logo image